Aurora Kinase Inhibitor III,
879127-16-9,
2np8,
N-{3-[(4-{[3-(trifluoromethyl)phenyl]amino}pyrimidin-2-yl)amino]phenyl}cyclopropanecarboxamide,
CHEMBL383899,
Cyclopropanecarboxylic acid-(3-(4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino)-phenyl)-amide,
N-[3-[[4-[3-(trifluoromethyl)anilino]pyrimidin-2-yl]amino]phenyl]cyclopropanecarboxamide,
Anilinopyrimidine1,
SCHEMBL676556,
GTPL5931,
CTK8E9807,
DTXSID20429557,
HMS3229A22,
HMS3229O19,
K00603a,
BDBM50200392,
IN1527,
MFCD09265250,
ZINC13831338,
AKOS017344660,
CCG-206736,
CCG-206818,
DB07545,
NCGC00167956-01,
CC3,
RT-011344,
6-[3-(Trifluoromethyl)anilino]-2-[3-(cyclopropylcarbonylamino)anilino]pyrimidine,
N-3-4-3-trifluoromethyl)phenylamino)pyrimidin-2-ylamino)phenyl)cyclopropanecarboxamide,
Cyclopropanecarboxylic acid {3-[4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino]-phenyl}-amide,
Cyclopropanecarboxylic acid {3-[4-(3-trifluoromethyl-phenylamino)-pyrimidin-2-ylamino]-phenyl}-amide, >=98% (HPLC), solid,
AuroraKinaseInhibitorIII,
D0Q3EW,
CID9549303,